期刊文献+

以腋窝淋巴结转移为首发症状的隐匿性乳腺癌临床分析 被引量:2

Clinical analysis of axillary lymph node metastasis as first symptom of occult breast cancer
原文传递
导出
摘要 目的:探讨伴腋窝转移的隐匿性乳腺癌(OBC)诊断、治疗及预后。方法:回顾性分析2000-03-2004-07收治的24例伴腋窝转移的OBC患者的临床资料。结果:24例术前触诊、钼钯和超声检查均未发现同侧乳腺确切肿物,术中病理示淋巴结转移癌(乳腺来源可能性大)。行同侧乳房切除加腋窝淋巴结清除术(术中剖开乳腺腺体9例发现原发灶),其3、5年总生存率分别为79.2%和66.7%。腋淋巴结转移数目<4者13例和≥4者11例,其3、5年生存率分别为84.6%、76.9%和72.7%、54.5%。结论:OBC应选择以同侧乳房切除加腋窝淋巴结清除术为主的综合治疗,特别是腋淋巴结转移数≥4者,治疗应更积极。 OBJECTIVE: To explore the diagnosis,treatment and prognosis in occult breast cancer patients with axillary lymph nodes metastasis.METHODS: The clinical data of 24 occult breast cancer patients with axillary lymph nodes metastasis from March 2000 to July 2004 were analyzed retrospectively.RESULTS: Twenty-four cases of preoperative palpation,molybdenum palladium and ultrasound examination were not found in the ipsilateral breast tumor exactly,but intraoperative frozen section of axillary tumor showed lymph node metastasis(breast was very likely the source).The ipsilateral mastectomy plus axillary lymph node dissection was performed(mammary gland cut open surgery,9 cases of primary tumor was found),and the 3-year and 5-year overall survival rates were 79.2% and 66.7% respectively.The number of axillary lymph node metastasis 4 was in 13 cases and ≥ 4 in 11 cases,and their 3-year and 5-year survival rates were 84.6%,76.9% and 72.7%,54.5% respectively.CONCLUSION: The comprehensive treatment based on ipsilateral mastectomy plus axillary lymph node dissection should be chose for OBC patients,in particular the number of ≥ 4 axillary lymph nodes,and the therapy should be more active.
出处 《中华肿瘤防治杂志》 CAS 2010年第13期1013-1014,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 淋巴结转移 预后 breast neoplasms lymphaitc metastasis prognosis
  • 相关文献

参考文献7

二级参考文献47

  • 1牛昀,范宇,傅西林.隐性乳腺癌的全乳腺次连续大切片检查[J].中华肿瘤杂志,1995,17(4):298-300. 被引量:34
  • 2毛杰,海健,刘少华,唐利立,申正堂,邬玉辉,欧慧英.隐匿性乳腺癌的诊断和治疗[J].肿瘤防治杂志,2005,12(19):1497-1498. 被引量:6
  • 3Tench DW, Page DL. The unknown primary presenting with axillary lymphadenopathy [ M ]//Bland KI, Copeland EM, editors. The breast:Comprehensive management of benign and malignant diseases. Vol2.2nd ed. Philadelphia: W. B. Saunders, 1998:1447 - 1452.
  • 4Orel SG, Hochman MG,Schnall MD, et al. High-resolution MR imaging of the breast: clinical context[ J ]. RadioGraphies, 1996, 16(6) :1385 - 1401.
  • 5Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer[J]. N Engl J Med,2007,356(13) :1295 -1303.
  • 6Olson JA Jr,Morris EA,Van Zee KJ,et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer [J]. Ann Surg Oncol,2000,7(6) :411 -415.
  • 7Schwartz GF,Hortobagyi GN. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26 - 28,2003, Philadelphia, Pennsylvania [ J ]. Cancer, 2004,100(12) :2512 -2532.
  • 8Vlastos G,Jean ME,Mirza AN,et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastasis [ J ]. Ann Surg Oncol,2001,8 (5) :425 - 431.
  • 9Merson M, Andreola S, Galimberti V, et al. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor[J]. Cancer,1992,70(2) :504 -508.
  • 10Varadarajan R, Edge SB, Yu J, et al. Prognosis of Occult Breast Carcinoma Presenting as Isolated Axillary Nodal Metastasis [ J ]. Oncology,2007,71 (5 - 6 ) :456 - 459.

共引文献29

同被引文献6

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部